Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-01-29

Clinical Trial Update: Post-Discharge Growth and Development of Infants Who Received Targeted Fortification in the NICU

View source ↗

Summary

The clinical trial evaluating post-discharge growth and development after targeted fortification in the NICU for premature infants is currently suspended.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Baylor College of Medicine | Conditions: Premature Infants | Status: SUSPENDED